Merck | MRK - Cost Of Sales

Stock Price
108.20
Daily Change
-3.25 -2.92%
Monthly
0.74%
Yearly
-11.24%
Q2 Forecast
108.96

Merck reported EUR2.29B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Adidas EUR 3.22B 235M Mar/2026
Adyen EUR 216.65M 97.06M Jun/2025
Akzo Nobel EUR 1.41B 28M Mar/2026
Alcon AG USD 1.2B 46M Dec/2025
Amadeus IT EUR 641.1M 260.4M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
AstraZeneca USD -204M 3.48B Mar/2026
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Danone EUR 6.73B 17M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.29B 163.12M Dec/2025
Henkel EUR 4.96B 110M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Infineon EUR 2.2B 235M Dec/2025
Linde USD 5.5B 1.12B Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
UCB EUR 1.07B 146M Dec/2025